Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Selecting the right IRA type for index funds hinges on your tax picture, contribution goals, and retirement timeline.
24,087 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
If you had $1,000 to put into a single stock this July, MercadoLibre could stand out for growth potential and a robus...
The chip market has cooled as investors weigh AI infrastructure costs. This piece highlights three AI chip stocks to ...
Taiwan Semiconductor's Q2 report is due July 16, shaping AI capex bets. Five stocks stand out as potential winners or...
A Monday surge put Archer Aviation stock in the spotlight as investors reacted to major eVTOL news. This guide breaks...
Federal Reserve Governor Michael S. Barr outlined three AI-driven labor-market futures, including a worst-case jobles...
Investors are buzzing about forum energy technologies stock as Q4 results point to improving demand in energy equipme...
Investors woke up to a jump in Micron shares after a period of volatility. This article breaks down the catalysts, th...
As investors await plug power (plug) 2025 Q4 results, this guide breaks down what the earnings call transcript could ...
Walmart has built a durable model, but three looming risks could erode its long-term edge. This guide breaks down tho...
Rising tensions near the Strait of Hormuz are driving fertilizer costs higher, prompting farmers to reassess spring p...